Table 2.
The diagnostic efficiency of different indicators for thyroid cancer before and after PSM
| Variable | Before or after PSM | Cutoff | AUC | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|---|
| CTC (FU/3 mL) | B | 7.55 | 0.553 | 69.5 | 43.5 |
| A | 7.55 | 0.537 | 65.6 | 45.8 | |
| TgAb (IU/mL) | B | 4.225 | 0.568 | 42.4 | 72.4 |
| A | 3.580 | 0.546 | 40.0 | 70.8 | |
| Ultrasound | B | – | 0.807 | 81.3 | 79.7 |
| A | – | 0.705 | 77.1 | 63.2 | |
| CTC + ultrasound | B | – | 0.820 | 81.4 | 80.0 |
| A | – | 0.718 | 79.3 | 61.7 | |
| CTC + TgAb + ultrasound | B | – | 0.827 | 81.5 | 80.0 |
| A | – | 0.724 | 78.0 | 63.3 |
PSM Propensity Score Matching, CTC circulating tumor cell, TgAb thyroglobulin antibody, AUC area under the curve, A after PSM, B before PSM